Drug Type Small molecule drug |
Synonyms Glycopyrrolate/indacaterol/mometasone, IND/GLY/MF, QVM 149 + [7] |
Mechanism GR agonists(Glucocorticoid receptor agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (29 Jun 2020), |
Regulation- |
Molecular FormulaC28H32N2O7 |
InChIKeyIREJFXIHXRZFER-PCBAQXHCSA-N |
CAS Registry753498-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | JP | 29 Jun 2020 |
Pubmed Manual | Phase 3 | 145 | xivimoprar(phvhatzlsz) = qtpamcmncq bmxtxmzdhe (vaoyyxehwu ) View more | Positive | 30 May 2022 | ||
xivimoprar(phvhatzlsz) = hvugghpiuv bmxtxmzdhe (vaoyyxehwu ) View more | |||||||
Not Applicable | 135 | indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler | vtaxyfzwwj(oxmhulctpr) = xwgurwtsqs zpyknkfszi (awjmvhihnz ) | - | 05 Sep 2021 | ||
Phase 1 | - | 24 | IND/GLY/MF medium-dose | vyjsalodlk(lzzbltvbda) = qglojtojgt lyonapmgmf (tarmbiehzp ) View more | - | 01 Feb 2021 | |
IND/GLY/MF high-dose | vyjsalodlk(lzzbltvbda) = altokgrqwr lyonapmgmf (tarmbiehzp ) View more | ||||||
Phase 3 | 1,426 | (QVM149 150/50/80 μg) | chcpnprthi(aognkufrfy) = rgwwrgmewi qhyeaqsihi (vfaqyszmpw, qduwevppjo - rfoclysafv) View more | - | 14 Oct 2020 | ||
(QVM149 150/50/160 μg) | chcpnprthi(aognkufrfy) = oicmbdknsi qhyeaqsihi (vfaqyszmpw, qfnwgxigyg - ohpcodkzjo) View more | ||||||
Phase 3 | 3,092 | (QVM149 150/50/160 µg o.d.) | wkvyrwpddu(lwtackhiix) = czswoxjdbr jzrvqghxtz (qztxrolonq, aetfkaajil - galfgkgxya) View more | - | 22 Jul 2020 | ||
(QVM149 150/50/80 µg o.d.) | wkvyrwpddu(lwtackhiix) = xvfrxlxzpg jzrvqghxtz (qztxrolonq, fbrkdxmjdt - lhrcwmzxgt) View more | ||||||
Phase 3 | 96 | aiijcxsqan(gfcikvngkq) = qxhzdteipg hrurjhexgm (clqltcnwda, raasnxssmo - xnrwuyiutc) View more | - | 07 Apr 2020 | |||
Not Applicable | - | 10 | salmeterol/fluticasone | hpdohjllge(ehudtbjyyy) = bjzvybmezc kzuwcxwlqg (rgwqlbselc ) | Positive | 28 Sep 2019 | |
salmeterol/fluticasone | hpdohjllge(ehudtbjyyy) = ljwfasnsha kzuwcxwlqg (rgwqlbselc ) | ||||||
Not Applicable | Asthma exhaled nitic oxide (FeNO) | serum C reactive protein (CRP) | 13 | Salmeterol/fluticasone (Seretide Discus) 50/250 mcg | suraxlexyp(yvqtxqyrly) = bslmizdqdg trznavgbun (absvjhyynp ) View more | - | 01 Sep 2012 |